Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NEFM DNA methylation correlates with immune infiltration and survival in breast cancer. | Clin Epigenetics | 2021 | 34001208 | PubTator, text mining | PubMed |
| Multiplex Immunofluorescence Tyramide Signal Amplification for Immune Cell Profiling of Paraffin-Embedded Tumor Tissues. | Front Mol Biosci | 2021 | 33996912 | PubTator, text mining | PubMed |
| Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to Mycobacterium tuberculosis. | Front Immunol | 2021 | 33995365 | PubTator, text mining | PubMed |
| Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3. | Pharmacol Ther | 2021 | 33992682 | PubTator, text mining | PubMed |
| FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036. | NPJ Breast Cancer | 2021 | 33980863 | PubTator, text mining | PubMed |
| HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer. | Cancer Cell Int | 2021 | 33962626 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Establishment of a novel double-monoclonal antibody sandwich enzyme-linked immunosorbent assay (ELISA): tool for human B7-H4 detection in autoimmune diseases. | Clin Exp Immunol | 2021 | 33961296 | PubTator, text mining | PubMed |
| The Predictive Value of Monocytes in Immune Microenvironment and Prognosis of Glioma Patients Based on Machine Learning. | Front Immunol | 2021 | 33959130 | PubTator, text mining | PubMed |
| Search for Genetic Predictors of Adult Autoimmune Polyendocrine Syndrome in Monozygotic Twins. | Clin Med Insights Endocrinol Diabetes | 2021 | 33953634 | PubTator, text mining | PubMed |
| Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma. | BMC Pulm Med | 2021 | 33952230 | PubTator, text mining | PubMed |
| Aging-related genes are potential prognostic biomarkers for patients with gliomas. | Aging (Albany NY) | 2021 | 33946049 | PubTator, text mining | PubMed |
| The Expression of Three Negative Co-Stimulatory B7 Family Molecules in Small Cell Lung Cancer and Their Effect on Prognosis. | Front Oncol | 2021 | 33937019 | PubTator, text mining | PubMed |
| MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer. | Cancer Med | 2021 | 33934540 | PubTator, text mining | PubMed |
| Identification of inhibitory immune checkpoints and relevant regulatory pathways in breast cancer stem cells. | Cancer Med | 2021 | 33932112 | PubTator, text mining | PubMed |
| The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy. | Front Immunol | 2021 | 33927723 | PubTator, text mining | PubMed |
| Depleting Tumor Cells Expressing Immune Checkpoint Ligands-A New Approach to Combat Cancer. | Cells | 2021 | 33921301 | PubTator, text mining | PubMed |
| Immune Checkpoints, Inhibitors and Radionuclides in Prostate Cancer: Promising Combinatorial Therapy Approach. | Int J Mol Sci | 2021 | 33921181 | PubTator, text mining | PubMed |
| Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs. | Cancers (Basel) | 2021 | 33918136 | PubTator, text mining | PubMed |
| SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment. | Cancers (Basel) | 2021 | 33917869 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=61